Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ATARA BIOTHERAPE RG (NQ: ATRA)
40.70 USD  UNCHANGED
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 25, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 387,036
Open 40.10
Bid (Size) 38.00 (1200)
Ask (Size) 41.50 (1000)
Prev. Close 40.70
Today's Range 38.60 - 40.75
52wk Range 11.80 - 49.90
Shares Outstanding 38,825,835
Dividend Yield N/A
Performance
YTD
+124.86%
+124.86%
1 Month
-1.09%
-1.09%
3 Month
+22.41%
+22.41%
6 Month
+186.62%
+186.62%
1 Year
+131.91%
+131.91%
Top News
More News
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported the... Read More
from GlobeNewswire News Releases
Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Multi-Color Corporation... Read More
from GlobeNewswire News Releases
More News
Read More
Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences
from GlobeNewswire News Releases
Technical Perspectives on Biotech Stocks -- Aimmune Therapeutics, Atara Biotherapeutics, AveXis, and Axsome Therapeutics
from PR Newswire
Atara Biotherapeutics to Present at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
from GlobeNewswire News Releases
Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
from GlobeNewswire News Releases
Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock
from GlobeNewswire News Releases
Analysts Predict 11% Gains Ahead For The Holdings of VFMO
category ETFs
from ETF Channel
Investors Snatch ATRA Even Lower Than Its Secondary Stock Offering
category Stocks
from Market News Video
3 Growth Stocks for Successful Investors
category ATRA , CRTO , SHOP
from Motley Fool
First Week of ATRA May 18th Options Trading
category Stocks
from Market News Video
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial

WHAT'S POPULAR IN THE VILLE